Aerpio Pharmaceuticals Inc (ARPO) Forecast, Price Target & Analyst Ratings

NASDAQ:ARPO

Current stock price

2.2
-0.02 (-0.9%)
At close:
2.28
+0.08 (+3.64%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Aerpio Pharmaceuticals Inc (ARPO).

Forecast Snapshot

Consensus Price Target

Price Target
$47.94
+ 2,079.09% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q3 / 2021
EPS Estimate
-$6.12
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
100.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$47.94
Upside
+ 2,079.09%
From current price of $2.20 to mean target of $47.94, Based on 2 analyst forecasts
Low
$47.47
Median
$47.94
High
$49.35

Price Target Revisions

1 Month
N/A
3 Months
N/A

Price Target Summary

2 Wall Street analysts provided a forecast for the next 12 months for ARPO. The average price target is 47.94 null. This implies a price increase of 2079.09% is expected in the next year compared to the current price of 2.2.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ARPO Current Analyst RatingARPO Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5

Analyst Ratings History

ARPO Historical Analyst RatingsARPO Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 0.5 1 1.5

Analyst Ratings Consensus

ChartMill Buy Consensus
100.00%
ARPO was analyzed by 2 analysts. The buy percentage consensus is at 100. So analysts seem to be very confident about ARPO.
In the previous month the buy percentage consensus was at a similar level.
Only 2 analysts analyzed ARPO. So this is just the average opinion of a couple of analysts.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2021-07-08HC Wainwright & Co.Upgrade Neutral -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q3 / 2021
EPS Estimate
-$6.12
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
-5,000.00%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2020 - 2025

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2018 2019 2020 2021 2022 2023 2024 2025
Revenue
YoY % growth
ARPO revenue by date.ARPO revenue by date.
N/AN/A
-100.00%		N/AN/A
-100.00%		N/AN/A
3.45%		N/A
5.00%		N/A
-100.00%
EBITDA
YoY % growth
ARPO ebitda by date.ARPO ebitda by date.
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ARPO ebit by date.ARPO ebit by date.
N/AN/AN/AN/AN/AN/AN/AN/A
Operating Margin
ARPO operating margin by date.ARPO operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
ARPO eps by date.ARPO eps by date.
N/A-0.55
86.52%		N/A
-289.45%		N/A
-892.86%		N/A
-30.94%		N/A
149.02%		N/AN/A
-100.63%

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 21 Q4 / 21 Q1 / 22 Q2 / 22 Q3 / 22 Q4 / 22
EPS
Q2Q % growth		-6.12
-5,000.00%		-3.98
-3,878.00%		-5.81
-6,360.00%		-6.58
-7,210.00%		-7.34
-20.00%		-7.96
-100.00%
Revenue
Q2Q % growth		486.184K972.369K1.459M
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		N/AN/AN/AN/AN/AN/A

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ARPO Yearly Revenue VS EstimatesARPO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2020 2022 2023 2024 5M 10M 15M 20M
ARPO Yearly EPS VS EstimatesARPO Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
34.35%
EPS Next 5 Year
14.84%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-41.69%
Revenue Next 5 Year
-14.87%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

Aerpio Pharmaceuticals Inc / ARPO Forecast FAQ

What do analysts expect the price target to be for Aerpio Pharmaceuticals Inc (ARPO)?

2 analysts have analysed ARPO and the average price target is 47.94 null. This implies a price increase of 2079.09% is expected in the next year compared to the current price of 2.2.

Can you provide the consensus estimates for Aerpio Pharmaceuticals Inc next earnings?

The consensus EPS estimate for the next earnings of Aerpio Pharmaceuticals Inc (ARPO) is -6.12 null and the consensus revenue estimate is 0 null.

Can you provide the consensus rating for Aerpio Pharmaceuticals Inc stock?

The consensus rating for Aerpio Pharmaceuticals Inc (ARPO) is 100 / 100 . This indicates that analysts generally have a positive outlook on the stock.